Economic evaluations of pharmacist-led medication review in outpatients with hypertension, type 2 diabetes mellitus, and dyslipidaemia: a systematic review.
Antonio Ahumada-CanaleCamila QuirlandFrancisco J Martinez-MardonesJosé Cristian Plaza-PlazaShalom Charlie I BenrimojVictoria García-CárdenasPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2019)
Pharmacist-led medication review has proven to be cost effective in various studies in different settings. Policy decision makers are advised to undertake local economic evaluations reflecting the gaps observed in this systematic review and published literature. If this is not possible, a transferability assessment should be conducted.